All In Biotech

Drug Trial Radar · NCT06664619

A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma

A 4-Week, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Trial of Fluticasone Propionate/Albuterol Sulfate Combination Compared to Fluticasone Propionate, Albuterol Sulfate or Placebo Delivered by Multidose Dry Powder Inhaler in Participants 12 Years and Older With Asthma

Last checked: Nov 20, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 649 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

649

Actual

Start

Dec 12, 2024

Primary completion

Oct 26, 2026

Study completion Oct 26, 2026

Sponsor

Sponsor type
Industry
First posted
Oct 29, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of the trial is to evaluate the efficacy of fluticasone propionate/albuterol sulfate multidose dry powder inhaler with electronic module (Fp/ABS eMDPI). Secondary objectives are: * To evaluate the efficacy of Fp/ABS eMDPI administered four times daily * To evaluate the safety and tolerability of Fp/ABS eMDPI administered four times daily over four weeks * To investigate the pharmacokinetics of Fp/ABS eMDPI, ABS eMDPI and Fp eMDPI after administration of a single dose The planned study duration for each participant is approximately 10 weeks, excluding an optional prescreening visit.

Conditions

  • Asthma

Interventions

  • Fp/ABSDrug

    Inhalation powder

  • FPDrug

    Inhalation powder

  • ABSDrug

    Inhalation powder

  • PlaceboDrug

    Inhalation powder

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from Baseline forced expiratory volume in one second (FEV1) area under the effect curve over 4 weeksTime frame: Baseline, Week 4
  2. Change from Baseline trough FEV1 at week 4Time frame: Baseline, Week 4

Locations

189 sites in 13 countries. Site status is shown where the registry gives one.

  • Arizona Medical Clinic

    Phoenix, Arizona

  • Central Phoenix Medical Clinic

    Phoenix, Arizona

  • Del Sol Research Management

    Tucson, Arizona

  • Novak Clinical Research

    Tucson, Arizona

  • Acuro Research, Inc

    Little Rock, Arkansas

  • Office Of Dr. Warren W. Pleskow MD

    Encinitas, California

  • Allergy and Asthma Specialist Medical Group and Research Center

    Huntington Beach, California

  • IMAX Clinical Trials

    La Palma, California

  • Allergy and Asthma Associates of Southern California

    Laguna Niguel, California

  • Ark Clinical Research

    Long Beach, California

  • Southern California Institute for Respiratory Diseases

    Los Angeles, California

  • California Allergy and Asthma Medical Group, Inc.

    Los Angeles, California

  • California Medical Research Associates Inc.

    Northridge, California

  • FOMAT Medical Research

    Oxnard, California

  • Northern California Research

    Sacramento, California

  • Allergy and Asthma Associates of Santa Clara Valley Research Center

    San Jose, California

  • Integrated Research of lnland, Inc.

    Upland, California

  • Synexus Clinical Research US, Inc.

    Vista, California

  • Allergy & Asthma Clinical Research, Inc.

    Walnut Creek, California

  • Critical Care, Pulmonary and Sleep Associates

    Lakewood, Colorado

  • Multi-Specialty Research Associates, Inc.

    Lake City, Florida

  • 3Sync, LLC

    Lake Worth, Florida

  • Optimal Research

    Melbourne, Florida

  • Angels Clinical Research Institute

    Miami, Florida

  • Suncoast Research Group LLC - Flourish

    Miami, Florida

  • Innova Pharma Research

    Miami, Florida

  • Florida Research Center, Inc.

    Miami, Florida

  • Diverse Clinical Research, LLC

    Miami, Florida

  • San Marcus Research Clinic Inc

    Miami Lakes, Florida

  • Oceanic Research Group, LLC

    North Miami Beach, Florida

  • Innovation Medical Research Center - Alcanza

    Palmetto Bay, Florida

  • D&H Pompano Research Center

    Pompano Beach, Florida

  • Clinical Research Trials of Florida, Inc

    Tampa, Florida

  • Oracle Clinical Research

    Conyers, Georgia

  • Treasure Valley Medical Research

    Boise, Idaho

  • Axis Clinical Research

    Westchester, Illinois

  • Care Access - Shreveport

    Shreveport, Louisiana

  • Patient First Clinical Trials

    Nottingham, Maryland

  • Continental Clinical Research Solutions, LLC

    Towson, Maryland

  • Chesapeake Clinical Research, Inc.

    White Marsh, Maryland

Showing 40 of 189 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.